Keyword: Bristol-Myers Squibb (BMS)
News
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
News
12.07.2012
- Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...
News
12.07.2012
- AstraZeneca has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost...
News
30.06.2012
- Simon Lowth may only be the interim chief executive of AstraZeneca but he is ready to sign off on bold deals. The decision to pair up with Bristol-Myers Squibb to buy diabetes...
News
02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
News
09.05.2012
- Teva Pharmaceutical Industries posted a 40 % jump in quarterly profit that beat estimates, boosted by robust sales of its own-branded products and generic medicines in the United...
News
27.04.2012
- U.S. drugmaker Bristol-Myers Squibb said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries...
News
26.04.2012
- Financier Carl Icahn said he has voluntarily dismissed a lawsuit filed against Amylin Pharmaceuticals after talking with the biotech company's chief executive, Daniel Bradbury...
